Circulating proteins in response to combined-modality therapy in rectal cancer identified by antibody array screening

BACKGROUND: The increasingly complex programs of contemporary cancer therapy emphasize the need for biological indicators of both therapeutic response and adverse effects. One example is combined-modality treatment aimed at improving long-term outcome in patients with locally advanced rectal cancer,...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:BMC Cancer
Egile Nagusiak: Kalanxhi, Erta, Hektoen, Helga Helseth, Meltzer, Sebastian, Dueland, Svein, Flatmark, Kjersti, Ree, Anne Hansen
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: BioMed Central 2016
Gaiak:
Research Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC4962367/
https://ncbi.nlm.nih.gov/pubmed/27461255
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12885-016-2601-x
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak